RELIEF THERAPEUTICS HOLDING ORD SHS
RLFTF
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.6M
Close$
$-0.19
187.4% downside
Current Fair Value
187.4% downsideOvervalued by 187.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.60 Million |
|---|---|
| Enterprise Value | $-1,983,664.00 |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $-0.48 |
| Beta | 1.23 |
| Outstanding Shares | 20,647,748 |
Return
| Return on Equity | -70.02% |
|---|---|
| Return on Assets | -57.04% |
| Return on Invested Capital | -72.94% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | 7.16 |
| Enterprise Value to EBIT | -0.89 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 8, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About MindMaze Therapeutics Holding S.A.
31 employees
CEO: Zach W. Henderson MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerl...